US News is a recognized leader in college, grad school, hospital, mutual fund, and car rankings. Track elected officials, research health conditions, and find news you can use in politics, business, health, and education.
THURSDAY, Jan. 22, 2026 (HealthDay News) — With more studies emerging, GLP-1 and dual GIP/GLP-1 medications have become well-established options for those with obesity or type 2 diabetes.
These treatments can positively affect appetite, metabolism an… [6869 chars]
Source: U.S. News & World Report | Published: 2026-01-22T11:05:00Z
Credit: U.S. News & World Report
